Data de publicação: 06/07/2022 - 14:06
Since the beginning of the pandemic, COVID-19 has been killing two children under 5 years old every day in Brazil. Overall, 599 children this age died of COVID-19 in 2020. In 2021, when the lethality of the disease increased among the entire population, the number of children victims of the virus jumped to 840. A total of 1,439 children below 5 years old died of COVID-19 in the country during the first two years of the pandemic. The Northeast...
Notícias
Data de publicação: 04/07/2022 - 13:35
With its continental size and heterogeneous landscapes, Brazil is home to a huge biodiversity of animals and plants and is therefore also a haven for a significant variety of pathogens and parasites - organisms that can cause disease. A study led by researchers of the Oswaldo Cruz Institute (IOC/Fiocruz) and published in Science Advances points to recent increases in the country’s social and ecological variabilities, associated to...
Notícias
Data de publicação: 24/06/2022 - 12:53
A research conducted by the Sabin Vaccine Institute and by Fiocruz Mato Grosso do Sul will evaluate the possibility of fractioning booster doses of vaccines for COVID-19. The research shall reveal if smaller doses can offer the same immunological response with fewer adverse reactions. It would allow to multiply the amount of vaccines, especially in poor countries, and guide new immunization strategies. According to Sabin Institute, only 17.4% of...
Notícias
Data de publicação: 24/06/2022 - 12:06
A new species of triatomine bugs, a subfamily of insects commonly known as ‘kissing bugs’, has been described by a group led by researchers of the Oswaldo Cruz Institute (IOC/Fiocruz). Christened Panstrongylus noireaui, the species belongs to a genus of high medical relevance due to its participation in the transmission of the Trypanosoma cruzi protozoan, which causes Chagas disease, in Central and South America. The finding was...
Notícias
Data de publicação: 24/06/2022 - 11:14
Fiocruz will be receiving a group of North-American students from Princeton University, in the United States. The exchange is the result of a memorandum of understanding between the institutions and will involve a total of seven students who will work at five different Fiocruz units. The first four members of the delegation arrived at the Foundation on June 9 and were welcomed with a lecture on the History of Health in Brazil given by Gilberto...
Notícias
Data de publicação: 14/06/2022 - 13:29
The need to detect and to promote a quick response to the possible emergence of monkeypox cases has led the Pan-American Health Organization (PAHO/WHO), the Ministry of Health and Fiocruz to promote, last Thursday and Friday (June 9 and 10), the first training for the laboratory diagnosis of the virus. The initiative, ministered by the Enterovirus Laboratory of the Oswaldo Cruz Institute (IOC/Fiocruz), had the participation of technicians from...
Notícias
Data de publicação: 10/06/2022 - 16:17
An influent figure in the field of science, technology and innovation, and former Portuguese minister, Manuel Heitor visited Fiocruz last Tuesday, June 7. The professor at the Superior Technical Institute of the University of Lisbon came with two missions: to further expand a collaborative laboratory program that Portuguese institutions already have with the Foundation and to look for new areas for collaboration. By the end of the visit, new...
Notícias
Data de publicação: 10/06/2022 - 11:54
As the first suspected cases of the monkeypox virus appear in Brazil, Fiocruz, through the Molecular Biology Institute of Paraná (IBMP, in the Portuguese acronym), has joined efforts in another pioneering initiative and has produced, in just a week, positive controls to help safely diagnose the disease. The first reagents were delivered to the Pan-American Health Organization (PAHO), the regional office of the World Health Organization (...
Notícias
Data de publicação: 08/06/2022 - 15:25
The Seventy-fifth World Health Assembly was held in Geneva, on 22-28 May 2022, with the theme "Health for peace, peace for health". For dozens of years, World Health Assemblies (WHAs) went unnoticed by the general public. However, since the emergence of the COVID-19 pandemic, they have been drawing the attention of politicians, diplomats and the civil society. Health has become an important part of the big policy. Not only because of...
Notícias
Data de publicação: 03/06/2022 - 14:33
Represented by its president, Nísia Trindade Lima, Fiocruz has been following the debates of the 75th World Health Assembly taking place in Geneva, Switzerland, from May 22 to May 28, with the theme Health for Peace, Peace for Health. The main decision-making agency of the World Health Organization (WHO), this space defines the global health agenda based on decisions, agreements and collaborations that will guide strategies for better...
Notícias
Data de publicação: 26/05/2022 - 12:02
In a study recently published in the scientific journal Nature, one of the most important in the world, researchers from the Oswaldo Cruz Foundation (Fiocruz) and the Telethon Institute of Genetics and Medicine (Tigem) in Italy, uncover the role of a key molecule for the replication of the Sars-CoV-2 virus, the agent of COVID-19. In an unprecedented way, scientists characterize the performance of nonstructural protein 6 (known by the acronym...
Notícias
Data de publicação: 24/05/2022 - 16:05
The rapid test TR Chagas Bio-Manguinhos, developed by the team led by researcher Fred Santos, from Fiocruz Bahia, was used for the first time in the population on Thursday (5/19), for a seroepidemiological survey of Chagas disease. The pilot project was carried out through a partnership with the Municipality of Tremedal, in Bahia, in residents of a rural area in the city, at the Municipal Health Department request.
Triatoma sordida...
Notícias
Data de publicação: 24/05/2022 - 15:57
A study led by the Oswaldo Cruz Institute (IOC/Fiocruz) registered, in images, the step-by-step of the infection process caused by the coronavirus (Sars-CoV-2) in Vero cells, obtained from monkey kidneys and widely used in research to understand pathogen biology and to develop treatments. Published in Viruses magazine, the work shows how the virus invades the cell, identifies the compartments where important steps of viral replication occur, and...
Notícias
Data de publicação: 24/05/2022 - 11:13
Some solutions found by Fiocruz for certain health issues in Brazil, including during the pandemic, could work as a basis for response in other countries. This was one of the conclusions of a group of representatives of Doctors Without Borders (DWB or MSF, in the acronym in portuguese), who visited the Foundation last monday (May 16). They discussed issues such as production and access to vaccines and medicines, effects of COVID-19 on...
Notícias
Data de publicação: 20/05/2022 - 17:15
On a six-day trip to Portugal, the president of the Oswaldo Cruz Foundation, Nísia Trindade Lima, was received by 14 Portuguese authorities, including three ministers, two rectors, an ambassador, and directors and presidents of institutions involving health, education, technology, and innovation, to deepen and structure inter-institutional cooperation between Fiocruz and Portuguese organizations. The trip took place between the last week...
Notícias
Data de publicação: 19/05/2022 - 11:56
Last Thursday (12 May) was the ceremony of donation of equipment to Fiocruz by the Japanese government, destined to the Immunobiological Technology Institute (Bio-Manguinhos) and the Oswaldo Cruz Institute (IOC). The donation is part of a cooperation project between Brazil and Japan to improve the institution’s capacity against COVID-19. On this occasion, delegations from the Japanese consulate, the Japanese International Cooperation...
Notícias
Data de publicação: 17/05/2022 - 17:10
Half the people diagnosed with COVID-19 present sequelae that may last for more than a year. This is one of the conclusions of a longitudinal study developed at Fiocruz Minas, which evaluated the effects of the disease over time. The research followed, for 14 months, 646 patients who had had the infection, and verified that 324 of them, that is, 50.2%, had post-infection symptoms, characterizing what the World Health Organization (WHO)...
Notícias
Data de publicação: 13/05/2022 - 16:36
During a visit to Fiocruz last Friday (6 May), the World Health Organization's (WHO) technical lead for COVID-19 response, Maria Van Kerkhove, debated the learnings and challenges necessary to maintain investments that were focused on the pandemic's preparedness for possible new public health emergencies. After getting to know more about the Foundation’s actions and visiting the Laboratory for Measles and Respiratory Viruses of the...
Notícias
Data de publicação: 13/05/2022 - 14:58
The complex dynamic of public health on Brazil’s borders with other South American countries and with the French Overseas Department of French Guiana is a challenge that must be faced in an increasingly integrated way with the different players that make up the health systems in these areas, on both sides of the international frontier. It was in the attempt to improve this relationship and to plan joint actions that representatives of the...
Notícias
Data de publicação: 10/05/2022 - 16:00
Beatriz Grinsztejn, infectiologist and head of the Laboratory of Clinical Research in STD and AIDS of the National Institute of Infectiology (INI/Fiocruz), received last Thursday (5/5), the award HIV Vaccine Network Service Award, granted during a 2022 HVTN/CoVPN Full Group Meeting, in Washington, USA. The award was given in recognition of her outstanding contribution to the network. The HIV Vaccine Trials Network (HVTN), based in Seattle, is...
Notícias
Data de publicação: 09/05/2022 - 15:07
On April 26, Fiocruz received a visit from the director of the Jenner Institute, University of Oxford, Adrian Hill. Within the scope of the Foundation's Deliberative Council, he was given a plaque in gratitude to him and his university team for the development of the Oxford/Astrazeneca vaccine, today produced 100% nationally at the Institute of Technology in Immunobiological (Bio-Manguinhos/ Fiocruz), after technology transfer. Then, the...
Notícias
Data de publicação: 09/05/2022 - 14:08
Through its Institute of Drug Technology (Farmanguinhos), Fiocruz signed last Tuesday (May 3) an agreement of technological cooperation with American pharmaceutical company MSD (Merck Sharp & Dohme). The goal is to manufacture in Brazil the first oral antiviral drug to treat COVID-19. Last Wednesday (May 4) afternoon, Brazil’s National Agency for Health Surveillance (Anvisa) released the authorization to use the drug in the country on...
Notícias
Data de publicação: 28/04/2022 - 15:05
“There are many nuclear missiles in the world. Why don’t we have enough plants to produce vaccines?” The demand came from Adrian Hill, director of the Jenner Institute, of the University of Oxford. One of the main developers of the Oxford/AstraZeneca COVID-19 vaccine, Hill attended the Symposium on Emerging and Persisting Global Health Threats, organized by Fiocruz and by the National Institute of Allergy and Infectious...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
